| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-10 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-09 |